According to the recent study the cardiovascular device market is projected to reach an estimated $116 billion by 2030 at a CAGR of 5% from 2023 to 2030. Growth in this market is primarily driven by growing demand for minimally invasive surgery, increasing healthcare expenditure, and growing geriatric population.
A more than 150 page
report to understand trends,
opportunity and forecast in cardiovascular device market by type
(cardiac rhythm management, interventional cardiac devices, peripheral vascular
devices, cardiac assist devices, structural heart devices, cardiovascular
surgery, electrophysiology, and diagnostic & monitoring devices), by device
(pacemaker, defibrillator, stent, cardiac catheter, guidewire, heart valve,
ECG, event monitor, and others), and region (North America, Europe, Asia
Pacific, and the Rest of the World).
Lucintel forecasts that
the structural heart device and electrophysiology are expected to be fastest
growing segment during the forecast period due to an increase in the geriatric
population burdened with various degenerative heart diseases.
CRM segment is expected
to remain the largest segment. Increasing use of defibrillators mainly due to
its cost effectiveness and safety is expected to result in significant growth
of the CRM market.
Download sample by clicking on cardiovascular device market
North America is
expected to remain the largest market during the forecast period mainly due to
presence of a large size target patient pool coupled with high adoption rate
for advanced treatments in this region.
Medtronic Public Limited
Company, Boston Scientific Corporation, Abbott Laboratories, Edwards
Lifesciences Corporation, and Johnson & Johnson are the major supplier in cardiovascular
device market.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1 972.636.5056
Explore Our Latest Publications
No comments:
Post a Comment